Department of Pharmaceutical Sciences, Eshelman School of Pharmacy, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.
Department of Cell Biology and Physiology, School of Medicine, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.
Nanomedicine. 2016 May;12(4):1053-1062. doi: 10.1016/j.nano.2015.12.382. Epub 2016 Jan 7.
UNLABELLED: The biological activity of nanoparticle-directed therapies critically depends on cellular targeting. We examined the subtumoral fate of Particle Replication in Non-Wetting Templates (PRINT) nanoparticles in a xenografted melanoma tumor model by multi-color flow cytometry and in vivo confocal tumor imaging. These approaches were compared with the typical method of whole-organ quantification by radiolabeling. In contrast to radioactivity based detection which demonstrated a linear dose-dependent accumulation in the organ, flow cytometry revealed that particle association with cancer cells became dose-independent with increased particle doses and that the majority of the nanoparticles in the tumor were associated with cancer cells despite a low fractional association. In vivo imaging demonstrated an inverse relationship between tumor cell association and other immune cells, likely macrophages. Finally, variation in particle size nonuniformly affected subtumoral association. This study demonstrates the importance of subtumoral targeting when assessing nanoparticle activity within tumors. FROM THE CLINICAL EDITOR: Particle Replication in Non-Wetting Templates (PRINT) technology allows the production of nanoparticles with uniform size. The authors in the study utilized PRINT-produced nanoparticles to investigate specific tumor uptake by multi-color flow cytometry and in vivo confocal tumor imaging. This approach allowed further in-depth correlation between nanoparticle properties and tumor cells and should improve future design.
未标记:纳米颗粒定向治疗的生物学活性取决于细胞靶向。我们通过多色流式细胞术和体内共聚焦肿瘤成像检查了Particle Replication in Non-Wetting Templates (PRINT)纳米颗粒在异种移植黑素瘤肿瘤模型中的亚肿瘤命运。这些方法与放射性标记的典型整体器官定量方法进行了比较。与放射性检测显示器官呈线性剂量依赖性积累相反,流式细胞术显示,随着颗粒剂量的增加,颗粒与癌细胞的结合变得与剂量无关,尽管与癌细胞的结合比例较低,但肿瘤中的大多数纳米颗粒都与癌细胞结合。体内成像显示肿瘤细胞与其他免疫细胞(可能是巨噬细胞)之间存在反比关系。最后,颗粒尺寸的变化不均匀地影响亚肿瘤的关联。这项研究表明,在评估肿瘤内纳米颗粒活性时,亚肿瘤靶向的重要性。
临床编辑按:Particle Replication in Non-Wetting Templates (PRINT) 技术允许生产具有均匀尺寸的纳米颗粒。研究中的作者利用 PRINT 生产的纳米颗粒通过多色流式细胞术和体内共聚焦肿瘤成像来研究特定的肿瘤摄取。这种方法允许在纳米颗粒特性和肿瘤细胞之间进行进一步的深入相关性分析,应能改进未来的设计。